What is Erlotinib (Tarceva)?
Mechanism of action of Erlotinib (Tarceva) Erlotinib (Tarceva, Genentech), is a targeted cancer treatment approved for treating chemotherapy-resistant advanced non-small cell lung cancer (NSCLC)....
View ArticleClinical Trials of Erlotinib (Tarceva) in Treatment of Advanced Non-Small...
Non-small cell lung cancer treated using Erlotinib. Non-small cell lung cancer (NSCLC) features among the leading cause of cancer mortality all over the world. New molecular targeted therapies like...
View ArticleNon-Small Cell Lung Cancer Therapy Enhanced – Combination Of RNAi With...
Combination of iRNA and TKI offer new dimensions to lung cancer therapy. Pic courtesy: http://www.nature.com/scitable/topicpage/gene-expression-14121669 New research published in the journal BMC...
View Article
More Pages to Explore .....